BCPEMI
ASMB icon

Bain Capital Public Equity Management II’s Assembly Biosciences ASMB Stock Holding History

Bain Capital Public Equity Management II’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29,834
Closed -$5.89M – 46
2020
Q3 		$5.89M Sell
29,834
-13,514
-31% -$3.4M 0.39% 32
2020
Q2 		$12.1M Buy
43,348
+29,413
+211% +$6.86M 0.93% 26
2020
Q1 		$2.48M Buy
13,935
+602
+5% +$129K 0.29% 31
2019
Q4 		$3.27M Buy
+13,333
New +$2.46M 0.31% 31

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Bain Capital Public Equity Management II's ASMB Position: Q4 2020 in Review

Bain Capital Public Equity Management II sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 29,834 shares — an estimated $5.89M sold.

Bain Capital Public Equity Management II first reported a position in ASMB in Q4 2019 and held it in 4 quarters. The position peaked at $12.1M in Q2 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Bain Capital Public Equity Management II reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Bain Capital Public Equity Management II sold 29,834 Assembly Biosciences shares in Q4 2020, an estimated $5.89M.
  • Bain Capital Public Equity Management II first reported a position in Assembly Biosciences in Q4 2019 and held it in 4 quarters.
  • Bain Capital Public Equity Management II's Assembly Biosciences position peaked at $12.1M in Q2 2020.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Bain Capital Public Equity Management II's 13F filing for Q4 2020, filed 16 Feb 2021.